2nd Quarter - Report

MCDERMOTT+ LLC for ADAPTIVE BIOTECHNOLOGIES

Firm
Client
Income
—
Expenses
—

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

FDA regulation of laboratory-developed tests.

LobbyistCovered position, as disclosed
PAUL RADENSKY —
ERIC ZIMMERMAN —

Contacted: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP)

Medicare/Medicaid MMM

Medicare reimbursement for laboratory-developed tests.

LobbyistCovered position, as disclosed
PAUL RADENSKY —
ERIC ZIMMERMAN —

Contacted: Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Medical/Disease Research/Clinical Labs MED

FDA regulation of laboratory-developed tests.

LobbyistCovered position, as disclosed
PAUL RADENSKY —
ERIC ZIMMERMAN —

Contacted: Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); SENATE; Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.